UK’s largest independent chemical manufacturer takes drug testing in-house with Intelligent Fingerprinting Drug Screening System
January 18 2024 - 8:30AM
Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the
“Company”), a medical technology company delivering intelligent,
rapid, non-invasive testing solutions, today announced that
Robinson Brothers, one of the UK’s largest independent chemical
manufacturers, is now using its revolutionary portable Intelligent
Fingerprinting Drug Screening System to support its drug and
alcohol testing policy.
Robinson Brothers runs a 24x7 chemical
manufacturing operation at its West Bromwich facility. The
company’s HR team found that its previously outsourced drug testing
provision was not responsive enough to support its requirements.
Adopting the Intelligent Fingerprinting Drug Screening System will
allow Robinson Brothers to bring drug testing in-house, with its
portability, flexibility and ease-of-use enabling random testing
across the business and for cause tests wherever and whenever
needed.
“We previously used an external provider to
carry out urine-based drug testing on a random basis. This was not
only unhygienic and intrusive for everyone involved, but also
invariably led to productivity delays as people sat around waiting
to be tested,” explained Steve Doyle, Human Resources Manager at
Robinson Brothers. “However, when we found out about
fingerprint-based drug screening, we immediately saw how we could
conduct our own testing in-house and in a much less invasive way.
Additionally, because the system is so portable and easy to use, it
works as an on-site visual deterrent and provides a great way of
supporting our Drug and Alcohol Policy across the business.”
“From our initial cost analysis, we see
fingerprint-based drug screening as highly cost-effective,” added
Steve. “Including the initial capital costs of the DSR-Plus drug
screening cartridge reader, we estimate that Intelligent
Fingerprinting will allow us to conduct the same volume of tests at
around half the cost. This, of course, becomes even more
competitive as capital costs are written down.”
“As a 24/7 manufacturing operation, Robinson
Brothers clearly appreciated the flexibility that sweat-based drug
testing provides, giving the HR team the ability to screen
employees whenever they need to,” added Harry Simeonidis, President
and Chief Executive Officer at Intelligent Bio Solutions. “What’s
clear is that our portable, non-invasive system takes the
complexity out of workplace drug testing and is increasingly
replacing traditional workplace testing methods using urine and
saliva.”
An introductory video demonstrating
fingerprint-based drug testing in action is available here.
About Intelligent Bio Solutions
Inc.Intelligent Bio Solutions Inc. (the “Company”)
(Nasdaq: INBS) is a medical technology company delivering
intelligent, rapid, non-invasive testing solutions. The Company
believes that its Intelligent Fingerprinting Drug Screening System
will revolutionize portable testing through fingerprint sweat
analysis, which has the potential for broader applications in
additional fields. This hygienic and cost-effective system is
designed to screen for recent use of drugs commonly found in the
workplace, including opiates, cocaine, methamphetamine, and
cannabis. With sample collection in seconds and results in under
ten minutes, this technology would be a valuable tool for employers
in safety-critical industries. Additionally, the Company’s
biosensor platform has the potential to test for up to 130
indications, ranging from glucose to immunological conditions and
communicable diseases. The Company’s current customer segments
include construction, manufacturing and engineering, transport and
logistics firms, drug treatment organizations, and
coroners.
For more information,
visit: www.ibs.inc
About Robinson BrothersFounded
in 1869, Robinson Brothers is one of the UK’s largest independent
chemical manufacturers, offering contract research and manufacture
as well as a significant number of its own in-house developed
molecules. The company operates across a number of markets,
including pharmaceutical, agrochemical, flavour and flagrance,
personal care, adhesives and coatings, and specialised polymer
additives. Core competencies include high-pressure hydrogenation,
carbon disulfide chemistry, amination, bromination, thiolation,
heterocyclic chemistry, dehydrogenation and oxidation. Robinson
Brothers also offers its own Robac Technology range that focuses
specifically on chemicals used in dry and wet rubber applications,
plus additional polymer additives.
For more information, visit
www.robinsonbrothers.co.uk
Forward-Looking Statements:Some
of the statements in this press release are forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934 and the
Private Securities Litigation Reform Act of 1995, which involve
risks and uncertainties. Forward-looking statements in this press
release include, without limitation, Intelligent Bio Solutions
Inc.’s ability to successfully develop and commercialize its drug
and diagnostic tests, realize commercial benefit from its
partnerships and collaborations, and secure regulatory approvals,
among others. Although Intelligent Bio Solutions Inc. believes that
the expectations reflected in such forward-looking statements are
reasonable as of the date made, expectations may prove to have been
materially different from the results expressed or implied by such
forward-looking statements. Intelligent Bio Solutions Inc. has
attempted to identify forward-looking statements by terminology,
including “believes,” “estimates,” “anticipates,” “expects,”
“plans,” “projects,” “intends,” “potential,” “may,” “could,”
“might,” “will,” “should,” “approximately” or other words that
convey uncertainty of future events or outcomes to identify these
forward-looking statements. These statements are only predictions
and involve known and unknown risks, uncertainties, and other
factors, included in Intelligent Bio Solutions’ public filings
filed with the Securities and Exchange Commission. Any
forward-looking statements contained in this release speak only as
of its date. Intelligent Bio Solutions undertakes no obligation to
update any forward-looking statements contained in this release to
reflect events or circumstances occurring after its date or to
reflect the occurrence of unanticipated events.
Company
Contact: Intelligent Bio Solutions
Inc. info@ibs.inc LinkedIn | Twitter
Media Contact: Cheryl
Billson, Comma Communications cheryl.billson@commacomms.com+44
(0)7791 720460
Intelligent Bio Solutions (NASDAQ:INBS)
Historical Stock Chart
From May 2024 to Jun 2024
Intelligent Bio Solutions (NASDAQ:INBS)
Historical Stock Chart
From Jun 2023 to Jun 2024